Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) announced a dividend on Wednesday, April 9th, NASDAQ Dividends reports. Stockholders of record on Friday, April 25th will be given a dividend of 2.40 per share on Monday, April 28th. The ex-dividend date is Tuesday, April 29th.
Aerovate Therapeutics Stock Down 1.5 %
AVTE opened at $2.68 on Friday. Aerovate Therapeutics has a 52 week low of $1.25 and a 52 week high of $25.29. The business’s 50 day moving average is $2.53 and its two-hundred day moving average is $2.53. The firm has a market cap of $77.68 million, a price-to-earnings ratio of -0.90 and a beta of 0.95.
Aerovate Therapeutics (NASDAQ:AVTE – Get Free Report) last announced its earnings results on Friday, April 25th. The company reported ($0.09) EPS for the quarter, beating analysts’ consensus estimates of ($0.30) by $0.21. Equities analysts expect that Aerovate Therapeutics will post -2.64 EPS for the current fiscal year.
Aerovate Therapeutics Company Profile
Aerovate Therapeutics, Inc, a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial.
Featured Stories
- Five stocks we like better than Aerovate Therapeutics
- Comparing and Trading High PE Ratio Stocks
- Texas Instruments: Earnings Beat, Upbeat Guidance Fuel Recovery
- 3 Best Fintech Stocks for a Portfolio Boost
- O’Reilly Automotive: An Anytime Buy for Buy-and-Hold Investors
- Consumer Discretionary Stocks Explained
- Chipotle Mexican Grill Serves Smoking Hot Entry Point in Q2
Receive News & Ratings for Aerovate Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aerovate Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
